The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex Pharmaceuticals said.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for moderate to severe acute pain. The drug, called Suzetrigine and manufactured by biotech company Vertex Pharmaceuticals,

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.